Cargando…
Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity
BACKGROUND: Bone metastases are a common cause of skeletal morbidity in patients with advanced cancer. The pattern of skeletal morbidity is complex, and the number of skeletal complications is influenced by the duration of survival. Because many patients with cancer die before trial completion, ther...
Autores principales: | Major, Pierre P, Cook, Richard J, Lipton, Allan, Smith, Matthew R, Terpos, Evangelos, Coleman, Robert E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739221/ https://www.ncbi.nlm.nih.gov/pubmed/19660124 http://dx.doi.org/10.1186/1471-2407-9-272 |
Ejemplares similares
-
Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features—An exploratory analysis of placebo-controlled trials
por: Coleman, Robert E., et al.
Publicado: (2013) -
BONE DISEASE
por: Terpos, Evangelos
Publicado: (2022) -
Bone-targeted therapies to reduce skeletal morbidity in prostate cancer
por: Dorff, Tanya B, et al.
Publicado: (2018) -
Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey
por: Santini, Daniele, et al.
Publicado: (2013) -
Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancer
por: Saylor, Philip J
Publicado: (2014)